{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-001737","form_type":"8-K","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2023-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.036897+00:00","generated_at":"2026-06-18T00:24:41.119491+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"dividend","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Predictive Oncology issues Series F Preferred Stock dividend to secure reverse split votes","bullets":["Board declared dividend of 1/1000th of a share of Series F Preferred for each common share, payable March 27, 2023.","Series F Preferred has 1,000 votes per share (1,000 votes per 1/1000th share) but only votes on reverse stock split.","Shares are non-transferable except with common; all not present at reverse split meeting will be automatically redeemed.","Redemption consideration is $0.10 per ten shares; shares also redeemable upon Board order or stockholder approval of reverse split."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-001737","json":"https://secwatch.observer/filing/0001171843-23-001737.json","markdown":"https://secwatch.observer/filing/0001171843-23-001737.md","text":"https://secwatch.observer/filing/0001171843-23-001737.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323001737/0001171843-23-001737-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323001737/f8k_031623.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T00:24:41.119491+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"db32f94d7a41ac29f8e4887522c6477b5c6d2262","claim":"Axe Compute Inc.: Board of Directors declared a dividend of Series F Preferred Stock and established its terms, including voting rights, transferability, dividend rights, liquidation preference, and redemption provisions (effective 2023-03-16).","evidence_excerpt":"On March 16, 2023, the board of directors (the “Board” ) of Predictive Oncology Inc. (the “Company” ) declared a dividend of one one-thousandth of a share of Series F Preferred Stock, par value $0.01 per share ( “Series F Preferred Stock” ), for each outstanding share of the Company’s common stock, par value $0.01 per share ( “Common Stock” ) to stockholders of record at 5:00 p.m. Eastern Time on March 27, 2023 (the “Record Date” ).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323001737/0001171843-23-001737-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-03-16"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}